Bolli N, D'Agostino M, Bagratuni T, Boccadoro M, Cavo M, Driessen C, Einsele H, Engelhardt M, Gay F, Gutiérrez NC, Hájek R, Holien T, João C, Kaiser M, Kortüm KM, Leypoldt L, Moreau P, Musto P, Ocio EM, Raab MS, Rasche L, Schjesvold F, Sevcikova T, Terpos E, Touzeau C et al. (2025)
European Myeloma Network Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma
Hemasphere, 9 (10), e70216
DOI 10.1002/hem3.70216, PubMed 41089883

Thorsteinsdóttir S, Lemonakis K, Slørdahl TS, Rögnvaldsson S, Richardson AK, Hermansen E, Thorsen J, Schjesvold F, Moore KLF, Szabo AG, Andersen MK, Waage A, Blimark CH, Vangsted A, Nordic Myeloma Study Group (2025)
Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group
Br J Haematol, 207 (4), 1638-1642
DOI 10.1111/bjh.70030, PubMed 41070698

Bertamini L, Fokkema C, Rodriguez-Otero P, van Duin M, Terpos E, D'Agostino M, van der Velden VHJ, van de Donk NWCJ, Delforge M, Driessen C, Hajek R, Einsele H, Vangsted AJ, Vieyra D, Attar RM, Sitthi-Amorn A, Carson R, Schjesvold F, Robak P, Beksac M, Spencer A, Broijl A, Cupedo T, Moreau P, Boccadoro M et al. (2025)
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
Blood (in press)
DOI 10.1182/blood.2025030113, PubMed 41060326